Mathangi Gopalakrishnan

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Patients Undergoing

Clinical Decision Support

Major Depressive Disorder

Drug Administration

Top Venues

Journal of clinical pharmacology

Clinical cancer research : an official journal of the American Association for Cancer Research

CPT: pharmacometrics & systems pharmacology

Psychiatric research and clinical practice

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaofeng Wang, Mathangi Gopalakrishnan, Benjamin Rich, Jogarao V Gobburu, Frank Larsen, Arash Raoufinia
Exposure-Response Modeling in Adults and Adolescents With Schizophrenia to Support the Extrapolation of Brexpiprazole Efficacy to Adolescents. Journal of clinical pharmacology (2024)
Mathangi Gopalakrishnan, Rodabe N Amaria
Project Optimus elicits the "holistic" benefits of PK/PD modeling of immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Mathangi Gopalakrishnan, Rodabe N Amaria
Project Optimus Elicits the "Holistic" Benefits of PK/PD Modeling of Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Brooke Langevin, Jogarao V S Gobburu, Mathangi Gopalakrishnan
Is There a Need for a Dedicated Pharmacokinetic Trial for a Drug in Obese Populations? A Drug Prioritization Decision Tree Framework. Journal of clinical pharmacology (2023)
Ahmed M Salem, Erik Dvergsten, Sanja Karovic, Michael L Maitland, Mathangi Gopalakrishnan
Model-based approach to identify predictors of paclitaxel-induced myelosuppression in "real-world" administration. CPT: pharmacometrics & systems pharmacology (2023)
Daniel Smolyak, Elizabeth M Humphries, Abhinav Parikh, Mathangi Gopalakrishnan, Fulden Aycan, Margrét Bjarnadóttir, Seth A Ament, Dina El-Metwally, Amber Beitelshees, Ritu Agarwal
Predicting Heterogeneity in Patient Response to Morphine Treatment for Neonatal Opioid Withdrawal Syndrome. Clinical pharmacology and therapeutics (2023)
Shamir N Kalaria, Michael Armahizer, Paul McCarthy, Neeraj Badjatia, Jogarao V Gobburu, Mathangi Gopalakrishnan
Development and Use of an Ex-Vivo In-Vivo Correlation to Predict Antiepileptic Drug Clearance in Patients Undergoing Continuous Renal Replacement Therapy. Pharmaceutical research 39 (5) (2022)
Ahmed M Salem, Tao Niu, Chao Li, Brady S Moffett, Vijay D Ivaturi, Mathangi Gopalakrishnan
Reassessing the Pediatric Dosing Recommendations for Unfractionated Heparin Using Real-World Data: a Pharmacokinetic-Pharmacodynamic Modeling Approach. Journal of clinical pharmacology (2021)
Mathangi Gopalakrishnan, Tiffany Farchione, Mitchell Mathis, Hao Zhu, Mehul Mehta, Ramana Uppoor, Islam Younis
Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration. Psychiatric research and clinical practice 3 (1) (2020)
Renu Singh, Shailly Mehrotra, Mathangi Gopalakrishnan, Ivana Gojo, Judith E Karp, Jacqueline M Greer, Alice Chen, Richard Piekarz, Brian F Kiesel, Jogarao Gobburu, Michelle A Rudek, Jan H Beumer, null null
Population pharmacokinetics and exposure-response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias. Cancer chemotherapy and pharmacology 83 (2) (2018)